Evidence mapPaperPMID 23715727Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2013

A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis.

Sevasti Zervou, Tanmoy Ray, Natasha Sahgal, Liam Sebag-Montefiore, Rebecca Cross, Debra J Medway, Philip J Ostrowski, Stefan Neubauer, Craig A Lygate

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Creatine deficiency and heart failure.Heart failure reviews · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Augmentation of Creatine in the Heart.Mini reviews in medicinal chemistry · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sevasti ZervouDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headington, Oxford, United Kingdom. szervou@well.ox.ac.uk
Tanmoy Ray
Natasha Sahgal
Liam Sebag-Montefiore
Rebecca Cross
Debra J Medway
Philip J Ostrowski
Stefan Neubauer
Craig A Lygate
University of Oxford · GBCentre for Human Genetics · GB

Funding

British Heart Foundation RG/10/002/28187Wellcome Trust 090532Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

Creatine is important for energy metabolism, yet excitable cells such as cardiomyocytes do not synthesize creatine and rely on uptake via a specific membrane creatine transporter (CrT; SLC6A8). This process is tightly controlled with downregulation of CrT upon continued exposure to high creatine via mechanisms that are poorly understood. Our aim was to identify candidate endogenous CrT inhibitors. In 3T3 cells overexpressing the CrT, creatine uptake plateaued at 3 h in response to 5 mM creatine but peaked 33% higher (P < 0.01) in the presence of cycloheximide, suggesting CrT regulation depends on new protein synthesis. Global gene expression analysis identified thioredoxin-interacting protein (Txnip) as the only significantly upregulated gene (by 46%) under these conditions (P = 0.036), subsequently verified independently at mRNA and protein levels. There was no change in Txnip expression with exposure to 5 mM taurine, confirming a specific response to creatine rather than osmotic stress. Small-interfering RNA against Txnip prevented Txnip upregulation in response to high creatine, maintained normal levels of creatine uptake, and prevented downregulation of CrT mRNA. These findings were relevant to the in vivo heart since creatine-deficient mice showed 39.71% lower levels of Txnip mRNA, whereas mice overexpressing the CrT had 57.6% higher Txnip mRNA levels and 28.7% higher protein expression compared with wild types (mean myocardial creatine concentration 124 and 74 nmol/mg protein, respectively). In conclusion, we have identified Txnip as a novel negative regulator of creatine levels in vitro and in vivo, responsible for mediating substrate feedback inhibition and a potential target for modulating creatine homeostasis.

Indexed as

3T3 CellsAnimalsBlotting, WesternCarrier ProteinsChromatography, High Pressure LiquidCreatineCycloheximideGene ExpressionHomeostasisMaleMembrane Transport ProteinsMiceMice, TransgenicMicroarray AnalysisMyocardiumProtein Synthesis InhibitorsCarrier ProteinsCreatinecreatine transporterCycloheximideMembrane Transport ProteinsProtein Synthesis InhibitorsRNA, MessengerRNA, Small InterferingThioredoxinsTxnip protein, mousecardiomyocytesredox

Identifiers

PMID23715727
PMCPMC3725544
OpenAlexW2080539182

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.